Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Barron's Recap: 16 All-Star Women Financial Advisors
Here's Why Sarepta Is Skyrocketing While BioMarin Is Falling
FDA Panel Seen As Bad For BioMarin, Good For Sarepta (Investor's Business Daily)
Related PPO
Stocks Hitting 52-Week Highs
Earnings Scheduled For March 4, 2015

Analysts at Goldman Sachs upgraded Team Health Holdings (NYSE: TMH) from “neutral” to “conviction buy.” The target price for Team Health has been raised from $33 to $43. Team Health's stock closed at $36.75 yesterday.

Analysts at Topeka Capital upgraded Polypore International (NYSE: PPO) from “hold” to “buy.” The target price for Polypore has been raised from $37 to $46. Polypore's shares closed at $39.13 yesterday.

JP Morgan upgraded CenturyLink (NYSE: CTL) from “neutral” to “overweight.” The target price for CenturyLink is set to $38. CenturyLink's shares closed at $35.06 yesterday.

Jefferies upgraded Ulta Salon, Cosmetics & Fragrance (NASDAQ: ULTA) from “hold” to “buy.” The target price for Ulta Salon has been raised from $85 to $100. Ulta Salon's shares closed at $82.00 yesterday.

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (CTL + PPO)

Get Benzinga's Newsletters